Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sotera Health Company - Common Stock (NQ:SHC)

12.16 -0.08 (-0.65%)
Streaming Delayed Price Updated: 11:07 AM EDT, Mar 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Sotera Health Company - Common Stock

< Previous 1 2 3 4 5 Next >
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 250 stocks hit new 52-week lows. 
Via Benzinga
Sotera Health: Q2 Earnings Insights
  Sotera Health (NASDAQ:SHC) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:15 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Expert Ratings For Sotera Health
Sotera Health (NASDAQ:SHC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Recap: Sotera Health Q4 Earnings
Sotera Health (NASDAQ:SHC) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:15 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 326 stocks hit new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Sotera Health's Return On Capital Employed Insights
According to Benzinga Pro, during Q1, Sotera Health (NASDAQ:SHC) earned $30.64 million, a 14.88% increase from the preceding quarter. Sotera Health's sales decreased to $236.75 million, a 1.86% change... 
Via Benzinga
Sotera Health Earnings Conference Call Is Coming Up, Here's What You Need To Know
Sotera Health (NASDAQ:SHC) will host a conference call at 09:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga
Analyst Ratings For Sotera Health
Over the past 3 months, 5 analysts have published their opinion on Sotera Health (NASDAQ:SHC) stock. These analysts are typically employed by large Wall Street banks and tasked... 
Via Benzinga
Expert Ratings For Sotera Health
Within the last quarter, Sotera Health (NASDAQ:SHC) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
Sotera Health Earnings Preview
Sotera Health (NASDAQ:SHC) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Upgrades 
Via Benzinga
Sotera Health Company (SHC) Q3 2021 Earnings Call Transcript
SHC earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Stocks That Hit 52-Week Lows On Friday
On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was... 
Via Benzinga
Why Sotera Health Stock Is Falling Today
Investors weren't happy with the company's full-year guidance. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... 
Via Benzinga
Sotera Health Company (SHC) Q2 2021 Earnings Call Transcript
SHC earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Sotera Health Company (SHC) Q1 2021 Earnings Call Transcript
SHC earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022
Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth... 
Via Benzinga
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:... 
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... 
Via Benzinga
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter. • ITeos Therapeutics (NASDAQ:ITOS... 
Via Benzinga
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
Via Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.